MedEarly.com
Title
News drugs Early
Description
Excerpted from the website:
- NEW YORK, NY -- June 3, 1998 – The United States Food and Drug Administration has approved Pfizer Inc. and UCB Pharma’s antihistamine Zyrtec(R) (cetirizine HCl) for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and chronic idiopathic urticaria in children down to the age of two years old. Zyrtec was initially approved for patients 12 y...